-
A-769662 for Reliable AMPK Assays
2026-08-20
This scenario-based guide explains how A-769662 (SKU A3963) can help researchers interpret viability, proliferation, cytotoxicity, and autophagy results without confusing metabolic modulation with cell death. It combines product specifications with current AMPK literature and practical assay-design recommendations.
-
T-5224: Linking AP-1 to Ferroptosis
2026-08-20
T-5224, a C-Fos/AP-1 inhibitor, offers a selective way to connect AP-1 transcriptional control with inflammatory, osteoclastogenic, and ferroptotic phenotypes. This article develops a mechanism-first framework for choosing assays, controls, and interpretation strategies across arthritis research and multiple myeloma models.
-
Phenothiazines, ROS, and Autophagy in Macrophages
2026-08-19
A 2025 Frontiers in Immunology study shows that phenothiazines strengthen macrophage antibacterial activity by increasing lysosomal function, autophagy, and reactive oxygen species. Its inhibitor and scavenger experiments support a host-directed mechanism that may help address intracellular infection without relying solely on direct bacterial killing.
-
SU6656: A Decision Framework for Two Cell Systems
2026-08-19
SU6656 is a Src tyrosine kinases inhibitor with distinct applications in cancer research and megakaryocyte biology. This evidence-led guide separates validated mechanisms from testable hypotheses and shows how to design stronger platelet and radiotherapy assays.
-
Diminazene Aceturate: Research Workflows
2026-08-18
Diminazene Aceturate supports two distinct experimental tracks: trypanocidal screening in parasite models and mechanistic ACE2 activation research in cardiac injury systems. This workflow-focused guide shows how to prepare, control, interpret, and troubleshoot the compound without conflating antiparasitic activity with mitochondrial protection.
-
Captopril Workflows for ACE Inhibition Research
2026-08-18
Captopril supports mechanistic ACE inhibition in hypertension research while offering a practical upstream tool for studying bradykinin-sensitive intestinal motility. This workflow-focused guide also shows how to evaluate reported anticancer activity without confusing preclinical findings with direct receptor evidence.
-
Resazurin Cell Viability Assay Kit in Redox Oncology
2026-08-17
Discover how the Resazurin Cell Viability Assay Kit can quantify treatment-associated metabolic changes while revealing the interpretive limits of redox-sensitive readouts. This guide uses parthenolide research to develop a more rigorous workflow for cell viability assay design, validation, and high-throughput oncology screening.
-
EZ Cap™ Cas9 mRNA (m1Ψ) for Reliable Editing
2026-08-17
Learn how EZ Cap™ Cas9 mRNA (m1Ψ), SKU R1014, can reduce variability in CRISPR-Cas9 genome editing workflows that feed into viability, proliferation, and cytotoxicity assays. This scenario-based guide connects Cap1 capping, m1Ψ modification, handling controls, and specificity-aware data interpretation with practical laboratory decisions.
-
L. plantarum DS0037 Nanovesicles as Senolytics
2026-08-16
A 2024 study identified Lactobacillus plantarum DS0037-derived exosome-like nanovesicles as a candidate material with both senolytic and senomorphic activity. The vesicles preferentially reduced senescent-cell survival, moderated inflammatory and matrix-remodeling markers, and showed short-term improvements in skin-elasticity measures, although their molecular cargo and long-term clinical performance remain unresolved.
-
Sildenafil Citrate: From PDE5 to Proteoform-Aware Assays
2026-08-15
Sildenafil Citrate is a cGMP-specific phosphodiesterase type 5 inhibitor with value beyond conventional PDE5 assays. This guide shows how to connect enzyme inhibition, vascular signaling, and native-membrane proteoform analysis to design more informative research workflows.
-
Efficient Synthesis of Deuterium-Labeled Degarelix
2026-08-14
The reference study reports a 13-step, 14% overall synthesis of deuterium-labeled degarelix acetate, using D2O/D3PO4-mediated aromatic deuteration to prepare a labeled amino-acid building block. The route provides a practical analytical standard for absorption, distribution, metabolism, and excretion studies while clarifying which conclusions apply to chemical synthesis rather than receptor pharmacology.
-
Deferasirox: Oral Iron Chelator Mechanisms
2026-08-14
Deferasirox is an oral iron chelator that binds trivalent iron and supports treatment of transfusion-related iron overload. Its ROS, NF-κB, and iron-metabolism effects also make it a useful preclinical probe, but the TCF25 starvation pathway and oncology applications require separate validation.
-
CXCR4 Theranostics in Lymphoma: Evidence and Limits
2026-08-13
This review frames CXCR4 as a theranostic target in lymphoma by connecting receptor biology, molecular imaging, and targeted treatment strategies. Its main contribution is an integrated view of peptide, small-molecule, radioligand, and antibody approaches, while also identifying physiological uptake and compensatory signaling as barriers to translation.
-
Ceftazidime as a Translational Resistance Probe
2026-08-13
Ceftazidime is more than a third-generation cephalosporin: it is a practical phenotypic probe for Pseudomonas aeruginosa, respiratory isolates, and β-lactam resistance. By connecting cell-wall biology with susceptibility testing, plasmid tracking, and hospital epidemiology, researchers can use Ceftazidime to build more defensible Gram-negative bacterial infection research workflows.
-
SmMAPK3–SmRAS1 Phosphorylation in Salvia
2026-08-12
This study identifies SmRAS1 as a direct SmMAPK3 substrate and shows that phosphorylation at Ser178 is required for salicylic acid-induced salvianolic acid accumulation in Salvia miltiorrhiza hairy roots. The work links elicitor signaling to metabolic enzyme stability through a kinase-dependent post-translational mechanism, offering a defined target for metabolic engineering while highlighting important limits of hairy-root and in vitro evidence.